ELGAR HOUSE
CHURCH ROAD, REDDITCH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 23 | 26 | 88.5% | |
| HF 4 | 2011 | 27 | 36 | 75.0% | |
| HF 4 | 2012 | 31 | 38 | 81.6% | |
| HF 4 | 2013 | 29 | 36 | 80.6% | |
| HF004 | 2014 | 26 | 34 | 76.5% | |
| HF004 | 2015 | 58 | 68 | 85.3% | |
| HF004 | 2016 | 63 | 70 | 90.0% | |
| HF004 | 2017 | 71 | 77 | 92.2% | |
| HF004 | 2018 | 79 | 83 | 95.2% | |
| HF004 | 2019 | 71 | 75 | 94.7% | |
| HF004 | 2020 | 68 | 77 | 88.3% | |
| HF006 | 2021 | 71 | 73 | 97.3% | |
| HF006 | 2022 | 77 | 83 | 92.8% | |
| HF006 | 2023 | 80 | 85 | 94.1% |
